Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 904-908-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From October 8th, 2018 to October 26th, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- February 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ECVAM DB-ALM protocol 155: KeratinoSens
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- Reaction Mass of Isoamyl salicylate and 2-Methylbutyl salicylate
- IUPAC Name:
- Reaction Mass of Isoamyl salicylate and 2-Methylbutyl salicylate
- Test material form:
- liquid
Constituent 1
In vitro test system
- Details on the study design:
- - Cell line used: KeratinoSens™ (Givaudan) cultured in maintenance medium (DMEM 1 g/l glucose, 9.1% non-heat inactivated foetal calf serum, 0.05% geneticin - stored at 5ºC ± 3ºC) at 37ºC, 5% CO2. Cells were exempt of mycoplasma.
- Passage number and level of confluence of cells: cells were used at passage 17 in repetition 1, passage 19 in repetition 2 and passage 21 in repetition 3.
- The cells were trypsinized according to the current working instruction IL 09. Cells suspension were adjusted to a density of 8.10^4 cells/ml in the seeding medium. 125 µl of the cell suspension at 8.10^4 cells/ml (i.e. 10^4 cells per well) were distributed in three white plates for the induction measurement and two transparent plates to assess the cytotoxicity. The seeded plates were incubated 24 hours ± 1 hour at 37 ºC, 5% CO2. The H12 wells were left without cells and allowed the measurement of blanks.
- Luminometer used: GloMax™ (Promega) MULTISKAN EX plate reader (Thermo life sciences) - reading range 0 - 3.5 units of Absorbance, linearity range 0 - 2.200 units of Absorbance
- Number of repetitions and replicates: the study was composed of three independent repetitions. For each repetition, the test item and the reference items were replicated on three independent plates for the measurement of induction and two plates for the measurement of cytotoxicity. Each repetition was performed on a different day with a fresh stock solution.
- Test chemical concentrations: Test item was diluted 100-fold (10X plate) in sterile water from a 200 mM stock solution and then diluted 25-fold in a new plate (4X plate). Finally, there was a further 4-fold dilution in the seeding plate
(1X plate). A positive control was diluted 100-fold in DMSO (Sigma Aldrich Batch no.W228613) from a 6.4 mM stock solution and then diluted 25-fold in a new plate in treatment medium and then further diluted 4-fold in the seeding plate. The test item was tested at 12 concentrations according to a geometric progression of ratio 2 from 0.98 µM to 2000 µM.
-Negative control: 6 wells of solvent control (1% DMSO in treatment medium) with cells and 1 well of solvent control without cell by culture plate. Positive control: 5 concentrations of cinnamaldehyde (SIGMA ALDRICH Batch no.W228613) on each culture plate. The concentration varies from 4 to 64 µM according to a geometric progression of ratio 2.
Description of evaluation and decision criteria used:
The test item is identified as potential skin sensitizer if the 4 following conditions are met in 2 of 2 or 2 of 3 repetitions. Otherwise, the keratinosens™ prediction is considered as negative:
1) The Imax is strictly 1.5 fold higher of the basal luciferase activity* statistically significantly to the value obtained for the negative control (as determined by a two-tailed, unpaired Student's t-test on the raw RLU values). If the Imax is exactly equal to 1.5, the test item is rated as negative and no EC1.5 value is calculated.
2) The EC1.5 value is strictly below 1000 μM (or <200 μg/ml for the test item with no defined molecular weight)
3) At the lowest concentration with a gene induction above 1.5, the cell viability must be strictly above 70% (i.e EC1.5 < IC70).
4) There is an apparent overall dose-response for luciferase induction, which is similar between the repetitions.
- Description of study acceptance criteria used:
1) Positive control:
- The gene induction must be statistically significant above the threshold of 1.5 in at least one dose.
- The EC1.5 value should be between IDEA Lab historical data: mean EC1.5 value ± 2 SD and the average induction, in each repetition, for cinnamaldehyde at 64 μM should be between 2 and 8. If the latter criterion is not fulfilled, the dose-response of cinnamaldehyde should be carefully checked, and tests may be accepted only if there is a clear dose-response with increasing luciferase activity induction at increasing concentrations for the positive control.
2) Negative control: for each repetition, the coefficient of variation of the solvent controls (3 x 6 wells) must be less than 20%. If for one repetition the validity criteria are not met, a third repetition should be considered.
Results and discussion
- Positive control results:
- Imax = 8.46
EC1.5 = 7.06 (geometric mean)
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- mean
- Parameter:
- other: Imax
- Value:
- 1.35
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Imax lower than 1.5, no EC1.5 is calculated
- Key result
- Run / experiment:
- other: Geometric mean
- Parameter:
- other: IC50
- Value:
- 2 000
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- The test item did not cause any precipitation or any other type of interference that might have had lead to confouding the possible sensitising effects of the test item.
DEMONSTRATION OF TECHNICAL PROFICIENCY: recommended substances for demonstrating technical proficiency with the KeratinoSens™ test method were tested to validate the method.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Average variability in yhr 3x6 control wells should be <20% (for each master plate).
- Acceptance criteria met for positive control:
1) Gene induction (luciferase activity) must be statistically significant > 1.5 in at least one dose. The luciferase activity was > in every single dose.
2) Average inductions in 3 replicates at 64 µM should be between 2-8, if this criterion is not fulfilled the test may be accepted based on dose-response: The average induction was 8.46, but there was an apparent overall dose-response for luciferase induction.
3) EC1.5 should be between 2 standard deviations of the historical mean (i.e 7-30 µM based on validation dataset: EC1.5 was 7.06 and therefore within the historical range (3-22 µM)
- Acceptance criteria met for variability between replicate measurements: yes, CV% < 20%
- Range of historical values if different from the ones specified in the test guideline: 3-22 µM
Any other information on results incl. tables
Table 1. Positive control results.
Cinnamaldehyde |
4 µM |
8 µM |
16 µM |
32 µM |
64 µM |
EC1.5 |
Imax |
Rep 1 |
1.33 |
2.18 |
3.77 |
6.00 |
15.17 |
4.80 |
15.17 |
Rep 2 |
1.37 |
1.45 |
2.12 |
3.16 |
5.52 |
8.58 |
5.52 |
Rep 3 |
1.24 |
1.45 |
2.13 |
3.22 |
4.69 |
8.56 |
4.69 |
Mean |
1.31 |
1.69 |
2.67 |
4.13 |
8.46 |
7.06* |
8.46 |
*geometric mean
Table 2. Negative Control Results.
Control solvent |
CV % |
Rep 1 |
10.5 |
Rep 2 |
8.8 |
Rep 3 |
6.8 |
Table 3. Test item results.
VIABILITY |
INDUCTION |
||||
ID-18/04211 |
IC50 |
IC30 |
Imax |
Linear EC1.5 |
EC1.5 Lin/Log |
Rep 1 |
53.17 |
44.96 |
1.51 |
30.76 |
30.58 |
Rep 2 |
53.85 |
36.30 |
1.11 |
- |
- |
Rep 3 |
71.36 |
53.15 |
1.42 |
- |
- |
Mean |
- |
- |
1.35 |
- |
- |
Geometric mean |
58.90 |
44.27 |
- |
- |
- |
Repetition 1: Imax is slightly higher than 1.5 (1.51) at only one concentration close to the IC30. The calculated EC1.5 is lower than 1000 µM and the EC1.5 viability is higher than 70%, the repetition is therefore positive. However the corresponding positive control being higher on this repetition, a third repetition was carried out.
Repetition 2 and 3: Imax is lower than 1.5, the EC1.5 is not determined. The repetition 2 and 3 are negatives.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- EU criteria
- Conclusions:
- The test item showed an Imax of 1.35 and an IC50 and IC30 higher than 2000 μM in KeratinoSens™. The test item showed no sensitisation potential under test conditions, therefore, the KeratinoSens prediction is considered negative.
- Executive summary:
The test method KeratinoSens™ has been performed as part of an integrated approach to support the identification of the sensitization potential of the test item according to OECD 442D, under GLP conditions.
The aim of the study is to evaluate the potential of the test item to activate the gene AKR1C2 y quantifying the luciferase induction after 48h in transformed keratinocytes. 12 concentrations of the test item ranging from 0.98 to 2000 μM were prepared by serial dilution in culture medium containing 1% DMSO and added to 96-well plates of KeratinoSens cells™, in 3 separate runs of 3 replicates each. Positive and negative controls were run in parallel, as well as a cytotoxicity assay (MTT reduction). All acceptance criteria were fulfilled for the positive and negative controls in each run. The test item showed an Imax of 1.35 and an IC50 and an IC30 higher than 2000 μM in KeratinoSens™, the mean cell viability was 58.90 and 44.27 for IC50 and IC30 respectively. Under the testing conditions the test item has no sensitisation potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.